These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia. Nellgård B, Wieloch T. J Cereb Blood Flow Metab; 1992 Jan; 12(1):2-11. PubMed ID: 1345757 [Abstract] [Full Text] [Related]
6. Differential effects of NMDA and AMPA/kainate receptor antagonists on nitric oxide production in rat brain following intrahippocampal injection. Radenovic L, Selakovic V. Brain Res Bull; 2005 Sep 30; 67(1-2):133-41. PubMed ID: 16140172 [Abstract] [Full Text] [Related]
7. Neuroprotective effects of the AMPA antagonist PNQX in oxygen-glucose deprivation in mouse hippocampal slice cultures and global cerebral ischemia in gerbils. Montero M, Nielsen M, Rønn LC, Møller A, Noraberg J, Zimmer J. Brain Res; 2007 Oct 26; 1177():124-35. PubMed ID: 17894933 [Abstract] [Full Text] [Related]
8. NMDA and AMPA/kainate glutamate receptors modulate dentate neurogenesis and CA3 synapsin-I in normal and ischemic hippocampus. Bernabeu R, Sharp FR. J Cereb Blood Flow Metab; 2000 Dec 26; 20(12):1669-80. PubMed ID: 11129783 [Abstract] [Full Text] [Related]
9. [Role of excitatory amino acids in neuropathology]. Wikinski SI, Acosta GB. Medicina (B Aires); 1995 Dec 26; 55(4):355-65. PubMed ID: 8728878 [Abstract] [Full Text] [Related]
10. NBQX, a competitive non-NMDA receptor antagonist, reduces degeneration due to focal spinal cord ischemia. von Euler M, Seiger A, Holmberg L, Sundström E. Exp Neurol; 1994 Sep 26; 129(1):163-8. PubMed ID: 7925838 [Abstract] [Full Text] [Related]
11. Comparing long-term depression with pharmacologically induced synaptic attenuations in young rat hippocampi. Xiao MY, Niu YP, Wigstrom H. Synapse; 1997 Aug 26; 26(4):329-40. PubMed ID: 9215592 [Abstract] [Full Text] [Related]
16. Posthypoxic reoxygenation-induced neurotoxicity prevented by free radical scavenger and NMDA/non-NMDA antagonist in tandem as revealed by dynamic changes in glucose metabolism with positron autoradiography. Murata T, Omata N, Fujibayashi Y, Waki A, Sadato N, Yoshimoto M, Wada Y, Yonekura Y. Exp Neurol; 2000 Aug 26; 164(2):269-79. PubMed ID: 10915566 [Abstract] [Full Text] [Related]
17. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy. Potschka H, Löscher W, Wlaź P, Behl B, Hofmann HP, Treiber HJ, Szabo L. Br J Pharmacol; 1998 Nov 26; 125(6):1258-66. PubMed ID: 9863655 [Abstract] [Full Text] [Related]
18. Glutamate-stimulated release of norepinephrine in hippocampal slices of animal models of attention-deficit/hyperactivity disorder (spontaneously hypertensive rat) and depression/anxiety-like behaviours (Wistar-Kyoto rat). Howells FM, Russell VA. Brain Res; 2008 Mar 20; 1200():107-15. PubMed ID: 18295191 [Abstract] [Full Text] [Related]
19. NMDA-receptor blockers but not NBQX, an AMPA-receptor antagonist, inhibit spreading depression in the rat brain. Nellgård B, Wieloch T. Acta Physiol Scand; 1992 Dec 20; 146(4):497-503. PubMed ID: 1283483 [Abstract] [Full Text] [Related]
20. Differential expression of NMDA and AMPA receptor subunits in rat dorsal and ventral hippocampus. Pandis C, Sotiriou E, Kouvaras E, Asprodini E, Papatheodoropoulos C, Angelatou F. Neuroscience; 2006 Jun 19; 140(1):163-75. PubMed ID: 16542781 [Abstract] [Full Text] [Related] Page: [Next] [New Search]